Chemical Structure : DT-061
CAS No.: 1809427-19-7
Catalog No.: PC-70158Not For Human Use, Lab Use Only.
SMAP (DT-061, NZ-8-061) is an orally bioavailable small molecule activator of PP2A, inhibits KRAS-driven tumor growth.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $198 | In stock | |
10 mg | $298 | In stock | |
25 mg | $458 | In stock | |
100 mg | $988 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SMAP (DT-061, NZ-8-061) is an orally bioavailable small molecule activator of PP2A, inhibits KRAS-driven tumor growth; acts by binding to the PP2A Aα scaffold subunit to drive conformational changes in PP2A.
SMAP (DT-061) inhibits the growth of KRAS-mutant lung cancers in mouse xenografts and transgenic models.
M.Wt | 520.523 | |
Formula | C25H23F3N2O5S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-((1R,2R,3S)-2-hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl)-4-(trifluoromethoxy)benzenesulfonamide, rel- |
1. Sangodkar J, et al. J Clin Invest. 2017 Jun 1;127(6):2081-2090.
2. Kauko O, et al. Sci Transl Med. 2018 Jul 18;10(450). pii: eaaq1093.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright